The FDA, no doubt, looks very unkindly on those wh

The FDA, no doubt, looks very unkindly on those who try to use it in some stock manipulation scheme and try to defraud them. If there is any frauding to be done, they want to control it.

I would expect the FDA has done an investigation into how Amarex and Cytodyn were trying to play them, have probably blacklisted Amarex and has sent what they found in their investigations to the DOJ which can figure out what they want to do with the info. Amarex was, no doubt, the most bonded party.

I would think virtually all of the misconduct at Amarex and Cytodyn would be attributed to Kazempour and Pourhassan. DOJ probably wouldn't treat the companies too badly but just let them fight among themselves.

But it has puzzled me how any arbitration or legal proceedings could proceed until the full culpability of the bad actors, Kazempour and Pourhassan and maybe the NSF CEO, had been determined.

In any event, matters may proceed forward because of insurance held by the companies. Then the insurance companies would be on the hook for the behavior of the bad actors and they would have to pursue any recovery of monies from them.

Isn't that how it would work?